Keith Fay

623 citations
7 papers · 277 indexed · 1 hit paper · h-index 4
Topics
CAR-T cell therapy research (5 papers)Lymphoma Diagnosis and Treatment (4 papers)Chronic Lymphocytic Leukemia Research (2 papers)

In The Last Decade

Keith Fay

5 papers receiving 273 citations

Hit Papers

Safety and efficacy of mosunetuzumab, a bispecific antibo...2022202620232024202250100150200

Peers

Keith Fay
Comparison fields: 5 of 36
  • Oncology 230
  • Pathology and Forensic Medicine 162
  • Radiology, Nuclear Medicine and Imaging 93
  • Immunology 70
  • Genetics 40
Replace Dena DeMarco with:
Dena DeMarco United States
Linda Lundberg Switzerland
James Relf Switzerland
Horst Hummel Germany
Yajuan Qin United States
Yngvild Nuvin Blaker Norway
Andy Chen United States
Cyrus Khan United States
Marie-Elisabeth Goebeler Germany
Michelle Poon Singapore
Keith Fay relative to Dena DeMarco United States Dena DeMarco's profile →
Citations per field
00.5×1.5×2.0×
Dena DeMarco · 1×
Citations per year

Countries citing papers authored by Keith Fay

Since Specialization
Citations

This map shows the geographic impact of Keith Fay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Fay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Fay more than expected).

Fields of papers citing papers by Keith Fay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Fay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Fay. The network helps show where Keith Fay may publish in the future.

Co-authorship network of co-authors of Keith Fay

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Fay. A scholar is included among the top collaborators of Keith Fay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Fay. Keith Fay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 5
2 1
3 0
4 0
5
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 studybreakdown →
244
6 21
7 6

About Keith Fay

Keith Fay is a scholar working on Dermatology, Pathology and Forensic Medicine and Genetics, having authored 7 papers that have together received 277 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (162 citations), Oncology (230 citations) and Radiology, Nuclear Medicine and Imaging (93 citations). Keith Fay has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include Elicia Penuel, Sarit Assouline, Lihua E. Budde, Laurie H. Sehn, Matthew J. Matasar, Stephen J. Schuster, Miguel Canales, John Kuruvilla, Matthew Ku and Michael C. Wei. Their work appears in journals such as Blood, The Lancet Oncology and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026